skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8847

Corrigendum: Efficacy and safety of travoprost alone or in combination with other agents for glaucoma and ocular hypertension: patient considerations

Corrigendum

(1097) Views  (213) Full article downloads

Authors: Suzuki Er, Suzuki CLB

Published Date December 2010 Volume 2010:4 Pages 1277 - 1278
DOI: http://dx.doi.org/10.2147/OPTH.S15855

Suzuki Er, Suzuki CLB

Corrected text

Two paragraphs on page 1168 of Suzuki & Suzuki were not cited correctly.

The data presented in the first paragraph should have been cited with reference number 35 and the following paragraph with a new reference, number 36. All subsequent references and citations were renumbered by one.

Original Article




 

Other articles by Dr Emilio Suzuki Jr.



Readers of this article also read:

Treatment of cystoid macular edema with the new-generation NSAID nepafenac 0.1%
Clinical utility and differential effects of prostaglandin analogs in the management of raised intraocular pressure and ocular hypertension
Measurement of treatment compliance using a medical device for glaucoma patients associated with intraocular pressure control: a survey
Efficacy and safety of travoprost alone or in combination with other agents for glaucoma and ocular hypertension: patient considerations
Divergence insufficiency associated with high myopia
Editorial
Improvement of adenoviral vector-mediated gene transfer to airway epithelia by folate-modified anionic liposomes
Corrigendum
Erratum
Ocular hypotensive effect and safety of travoprost 0.004%/timolol maleate 0.5% fixed combination after change of treatment regimen from ß-blockers and prostaglandin analogs